| Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism M Lucijanic, I Krecak, E Soric, M Sedinic, A Sabljic, L Derek, O Jaksic, ... Blood cancer journal 11 (11), 189, 2021 | 30 | 2021 |
| Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis M Lucijanic, D Galusic, I Krecak, M Sedinic, H Holik, V Perisa, ... Annals of hematology 99, 2779-2785, 2020 | 28 | 2020 |
| Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera I Krečak, H Holik, MP Martina, I Zekanović, B Coha, V Gverić-Krečak International journal of hematology 112 (3), 377-384, 2020 | 24 | 2020 |
| High red blood cell distribution width might predict thrombosis in essential thrombocythemia and polycythemia vera I Krečak, F Krečak, V Gverić-Krečak Blood cells molecules and diseases 80, 2020 | 20 | 2020 |
| Advances in risk stratification and treatment of polycythemia vera and essential thrombocythemia I Krecak, M Lucijanic, S Verstovsek Current hematologic malignancy reports 17 (5), 155-169, 2022 | 18 | 2022 |
| Renal disease associated with chronic myeloproliferative neoplasms M Lucijanic, I Krecak, R Kusec Expert review of hematology 15 (2), 93-96, 2022 | 18 | 2022 |
| Neutrophil‐to‐lymphocyte and platelet‐to‐lymphocyte ratios as prognostic biomarkers in polycythemia vera I Krečak, H Holik, M Morić Perić, I Zekanović, B Coha, M Valovičić Krečak, ... International journal of laboratory hematology 44 (4), e145-e148, 2021 | 15 | 2021 |
| Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis M Lucijanić, I Krečak, E Sorić, A Sabljic, D Galušić, H Holik, V Periša, ... Leukemia research 119, 2022 | 13 | 2022 |
| Thrombotic risk in secondary polycythemia resembles low-risk polycythemia vera and increases in specific subsets of patients I Krečak, H Holik, I Zekanović, M Morić Perić, T Marketin, B Coha, ... Thrombosis research 209, 47-50, 2022 | 12 | 2022 |
| No impact of the increased number of cardiovascular risk factors on thrombosis and survival in polycythemia vera I Krečak, M Morić Perić, I Zekanović, H Holik, B Coha, V Gverić-Krečak, ... Oncology research and treatment 44 (4), 201-203, 2021 | 12 | 2021 |
| Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis M Lucijanic, I Krecak, D Galusic, M Sedinic, H Holik, V Perisa, ... Wiener klinische Wochenschrift, 1-7, 2021 | 12 | 2021 |
| High platelet-to-lymphocyte ratio may differentiate polycythemia vera from secondary polycythemia I Krečak, H Holik, M Morić Perić, I Zekanović, B Coha, V Gverić-Krečak, ... Wiener klinische Wochenschrift 134 (11), 483-486, 2022 | 10 | 2022 |
| Estimating plasma volume using the Strauss‐derived formula may improve prognostication in polycythemia vera I Krečak, I Zekanović, H Holik, M Morić Perić, B Coha, V Gverić‐Krečak International journal of laboratory hematology, 2021 | 10 | 2021 |
| The impact of statins on the intensity of phlebotomies in polycythemia vera I Krečak, H Holik, M Morić-Perić, I Zekanović, B Coha, V Gverić-Krečak Annals of hematology 99 (4), 911-912, 2020 | 10 | 2020 |
| Identifying patients with polycythemia vera at risk of thrombosis after hydroxyurea initiation: the Polycythemia Vera—Advanced Integrated Models (PV-AIM) Project S Verstovsek, I Krečak, FH Heidel, V De Stefano, K Bryan, MW Zuurman, ... Biomedicines 11 (7), 1925, 2023 | 9 | 2023 |
| Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis M Lucijanic, I Krecak, E Soric, A Sabljic, D Galusic, H Holik, V Perisa, ... Biochemia medica 33 (2), 2023 | 9 | 2023 |
| Beneficial effect of ACE inhibitors on kidney function in polycythemia vera I Krečak, M Morić Perić, I Zekanović, H Holik, B Coha, V Gverić-Krečak, ... Wiener klinische Wochenschrift, 1-8, 2021 | 9 | 2021 |
| Hyperuricemia might promote thrombosis in essential thrombocythemia and polycythemia vera I Krečak, M Lucijanić, V Gverić-Krečak, N Duraković Leukemia & lymphoma 61 (7), 1744-1747, 2020 | 9 | 2020 |
| Higher red blood cell distribution width predicts thrombosis risk in primary and secondary myelofibrosis M Lucijanic, I Krecak, S Verstovsek, E Soric, D Galusic, H Holik, V Perisa, ... Annals of hematology 101 (6), 1355-1357, 2022 | 8 | 2022 |
| Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera I Krečak, H Holik, B Coha, MM Perić, I Zekanović, MV Krečak, ... Annals of hematology 100, 1335-1336, 2021 | 8 | 2021 |
